Thyroid cancer risk among patients exposed to diagnostic doses of iodine-131
Creators
Description
The level of risk associated with Iodine 131 is not well define but appears lower than equivalent doses of x-rays. To provide quantitative data on the risk of thyroid cancer following Iodine 131 exposure, 34104 patients surviving ≥5 years after Iodine 131 administration between 1950-69 for diagnostic purposes were studied. The mean thyroid dose was estimated to be 1.1 Gy (range 0-40.5). Overall, 67 thyroid cancers occurred in contrast to 49.7 expected based on rates from the general population (SIR = 1.35 -Standardized Incident Ratio-; 95% CI 1.05-1.71 -Confidence Intervals-). However, the excess rates was based entirely among patients referred because of a suspicion of a thyroid tumour whose risk was significantly higher than for those referred for other reasons. (Author). 20 refs
Additional details
Publishing Information
- Publisher
- Organisation for Economic Co-Operation and Development.
- Imprint Place
- Paris (France)
- ISBN
- 92-64-14689-X
- Imprint Title
- The implementation of short-term countermeasures after a nuclear accident (stable iodine, sheltering and evacuation)
- Imprint Pagination
- 318 p.
- Journal Page Range
- p. 33-39.
Conference
- Title
- Workshop on the Implementation of Short-Term Countermeasures after a Nuclear Accident.
- Dates
- 1-3 Jun 1994.
- Place
- Stockholm (Sweden).
INIS
- Country of Publication
- France
- Country of Input or Organization
- Nuclear Energy Agency of the OECD (NEA)
- INIS RN
- 28001477
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- ADOLESCENTS; AGE GROUPS; CHILDREN; IODINE 131; NEOPLASMS; POST-IRRADIATION THERAPY; PUBLIC HEALTH; RADIATION DOSES; RADIATION HAZARDS; RADIATION INJURIES; THYROIDITIS
- Descriptors DEC
- ANIMALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; DAYS LIVING RADIOISOTOPES; DISEASES; ENDOCRINE DISEASES; HAZARDS; HEALTH HAZARDS; INJURIES; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MAMMALS; MAN; MEDICINE; NUCLEI; ODD-EVEN NUCLEI; PREVENTIVE MEDICINE; PRIMATES; RADIATION EFFECTS; RADIOISOTOPES; THERAPY; VERTEBRATES